CYP19A1 and osteoporosis: Males are usually diagnosed later in life, are tall due to delayed epiphyseal closure and have osteoporosis due to impaired bone mineralisation; these clinical features are comparable to those seen in patients with oestrogen receptor mutations; altered testis size and spermatogenesis may also be due to aromatase deficiency [15,20].